<- Go Home
ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Market Cap
$6.0M
Volume
531.0K
Cash and Equivalents
$762.4K
EBITDA
-$5.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$11.96
52 Week Low
$2.90
Dividend
N/A
Price / Book Value
2.52
Price / Earnings
-0.54
Price / Tangible Book Value
2.52
Enterprise Value
$5.7M
Enterprise Value / EBITDA
-1.04
Operating Income
-$5.8M
Return on Equity
291.56%
Return on Assets
-86.73
Cash and Short Term Investments
$762.4K
Debt
$492.4K
Equity
$2.3M
Revenue
N/A
Unlevered FCF
-$6.0M
Sector
Health Care Equipment and Supplies
Category
N/A